Papel del cirujano plástico en una Unidad de Mama: 20 años de experiencia / Role of Plastic Surgeon in Breast Unit: 20 years review

Cada vez más, con el fin de alcanzar un resultado final integral óptimo, las Unidades de tratamiento del cáncer de mama requieren las habilidades de un cirujano plástico reconstructor. En nuestra Unidad, desde hace más de 20 años, se entiende como calidad asistencial la suma de competencia oncológica y habilidad reconstructiva. Por ello se incorpora como miembro integral del equipo clínico la figura del cirujano plástico, aportando criterios estéticos a la cirugía oncológica aplicando las técnicas de cirugía oncoplástica. En este artículo analizamos la evolución de la cirugía oncoplástica en los últimos 20 años, demostrando la importancia del cirujano plástico como miembro integral de Unidad de Patología Mamaria (AU)

Increasingly, in order to achieve optimum overall outcome, Units breast cancer treatment requires the skills of a reconstructive plastic surgeon. In our Unit, for more than 20 years, is understood as the sum of oncologic competence and reconstructive skill. So, plastic surgeon is incorporated as an integral member of the clinical team, providing aesthetic criteria oncologic surgery using oncoplastic surgical techniques. In this paper we analyze the evolution of oncoplastic surgery in the past 20 years, demonstrating the importance of the plastic surgeon as an integral member of Breast Pathology Unit (AU)

The role of plastic surgery in sarcoma treatment

INTRODUCTION: Sarcomas are low-incidence tumours, but their poor prognosis and complex treatment require the work of a multidisciplinary medical team. The Plastic Surgery Service forms part of the Sarcoma Functional Unit in our centre, performing tumour exeresis as well as immediate reconstruction. MATERIALS AND METHODS: We present a retrospective study on the experience of the Plastic Surgery Service of the Hospital Universitario de Bellvitge in the treatment of 133 sarcomas over 20 years. RESULTS: The surgical treatment was based on local radical surgery supported by primary reconstructive surgery in 42.9% of the cases, with an amputation rate in limb sarcomas of 9.7%. Radiotherapy and chemotherapy were used in the high-grade sarcomas as adjuvant treatment. The anatomical location of the head and neck was associated with the need for reconstructive procedures. Survival free from local recurrence was 84.72% at 5 years. Disease-specific survival was 81.22% at 5 years. The only prognostic factor for survival in our series was histological grade. CONCLUSIONS: Primary reconstructive surgery has a fundamental role in sarcoma treatment enabling radical surgical resection, avoiding amputations and facilitating adjuvant treatments (AU)